REVB
Price
$3.08
Change
+$0.24 (+8.45%)
Updated
Jul 18, 02:10 PM (EDT)
Capitalization
4.36M
TSHA
Price
$2.57
Change
-$0.02 (-0.77%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
677.36M
31 days until earnings call
Interact to see
Advertisement

REVB vs TSHA

Header iconREVB vs TSHA Comparison
Open Charts REVB vs TSHABanner chart's image
Revelation Biosciences
Price$3.08
Change+$0.24 (+8.45%)
Volume$3.16K
Capitalization4.36M
Taysha Gene Therapies
Price$2.57
Change-$0.02 (-0.77%)
Volume$29.04K
Capitalization677.36M
REVB vs TSHA Comparison Chart in %
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. TSHA commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (REVB: $2.84 vs. TSHA: $2.59)
Brand notoriety: REVB and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 15% vs. TSHA: 89%
Market capitalization -- REVB: $4.36M vs. TSHA: $677.36M
REVB [@Biotechnology] is valued at $4.36M. TSHA’s [@Biotechnology] market capitalization is $677.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, REVB is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • REVB’s TA Score: 3 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, REVB is a better buy in the short-term than TSHA.

Price Growth

REVB (@Biotechnology) experienced а +0.53% price change this week, while TSHA (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.33%. For the same industry, the average monthly price growth was +13.96%, and the average quarterly price growth was +35.38%.

Reported Earning Dates

REVB is expected to report earnings on May 08, 2025.

TSHA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+3.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($677M) has a higher market cap than REVB($4.36M). TSHA YTD gains are higher at: 49.711 vs. REVB (-87.166). REVB has higher annual earnings (EBITDA): -8.14M vs. TSHA (-85.47M). REVB has less debt than TSHA: REVB (0) vs TSHA (61.4M). TSHA has higher revenues than REVB: TSHA (7.22M) vs REVB (0).
REVBTSHAREVB / TSHA
Capitalization4.36M677M1%
EBITDA-8.14M-85.47M10%
Gain YTD-87.16649.711-175%
P/E RatioN/A2.70-
Revenue07.22M-
Total CashN/A117M-
Total Debt061.4M-
TECHNICAL ANALYSIS
Technical Analysis
REVBTSHA
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TR37.991.73
+4.77%
Tootsie Roll Industries Inc
RSI14.730.07
+0.48%
Rush Street Interactive
UDR40.64-0.03
-0.07%
UDR
VRAX0.92N/A
-0.11%
Virax Biolabs Group Limited
OCFT7.50-0.02
-0.27%
OneConnect Financial Technology Co Ltd

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
-1.05%
GNPX - REVB
48%
Loosely correlated
-3.18%
TCRT - REVB
46%
Loosely correlated
+0.31%
OGEN - REVB
34%
Loosely correlated
+0.70%
IMUX - REVB
33%
Poorly correlated
+3.82%
NTLA - REVB
31%
Poorly correlated
-1.09%
More